Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak (DolPsyCOVID)
December 10, 2020 updated by: University Hospital, Lille
In the context of quarantine with COVID-19, we will study the experience and psychological impact of pain in adult patients living with chronic pain.
We will evaluate the link between the question of physical and psychological confinement in the experience of pain in this particular situation
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
312
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lille, France, 59037
- Hôpital Roger Salengro, CHU Lille
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
RA patient will be interviewed par internet questionnaire (patient association / AFVD)
Description
Inclusion Criteria:
- Patient with chronic pain
- Patient in confinement
- Patient with sufficient understanding of the French language
Exclusion Criteria:
- Non adult patient
- patient without quarantine
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
patient with chronic painful
|
questionnaire assesment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Hospital Anxiety and Depression Scale questionnaire
Time Frame: 1 week from baseline on
|
1 week from baseline on
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Quality of life (SF36)
Time Frame: 1 week from baseline on
|
1 week from baseline on
|
|
self-reported questionnaire for painful
Time Frame: 1 week from baseline on
|
1 week from baseline on
|
|
qualitive questionnaire
Time Frame: 1 week from baseline on
|
1 week from baseline on
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Anne BERA, MD, University Hospital, Lille
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 20, 2020
Primary Completion (Actual)
April 27, 2020
Study Completion (Actual)
April 27, 2020
Study Registration Dates
First Submitted
April 15, 2020
First Submitted That Met QC Criteria
April 15, 2020
First Posted (Actual)
April 20, 2020
Study Record Updates
Last Update Posted (Actual)
December 11, 2020
Last Update Submitted That Met QC Criteria
December 10, 2020
Last Verified
May 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020_45
- 2020-A00912-37 (Other Identifier: ID-RCB number,ANSM)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.